Literature DB >> 21088043

Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol.

Gwenaëlle Le Pen1, Thérèse M Jay, Marie-Odile Krebs.   

Abstract

Exposure to methylazoxymethanol (MAM) at embryonic day 17 (E17) in the rat has been proposed to be a promising model for schizophrenia that mimics behavioural abnormalities and deficits in prefrontal cortex (PFC) networks. In this study, we investigated for the first time the effects of antipsychotics on abnormal behaviours observed in prenatally MAM-exposed rats. We first examined spontaneous and MK-801-induced locomotor activity in an open field in adult E17 MAM- or saline-exposed rats. Then, the effect of single injections of haloperidol, clozapine and risperidone was investigated in MAM- or sham-exposed rats on spontaneous and MK-801 (0.05 mg/kg)-induced hyperactivity. Risperidone more selectively counteracted the spontaneous hyperactivity in MAM than in sham rats, while haloperidol and clozapine induced similar effects on spontaneous locomotion in both groups. The main result of this study is that all the tested antipsychotics were more effective in attenuating the MK-801-induced hyperlocomotion in MAM than in sham rats. These findings further support the validity of E17 MAM exposure as a model for schizophrenia and add to its heuristic value in screening therapies for schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088043     DOI: 10.1177/0269881110387839

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  8 in total

1.  Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3β.

Authors:  Bo Xing; Genie Han; Min-Juan Wang; Melissa A Snyder; Wen-Jun Gao
Journal:  Neuropharmacology       Date:  2018-05-14       Impact factor: 5.250

2.  Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.

Authors:  Jana Ruda-Kucerova; Zuzana Babinska; Tibor Stark; Vincenzo Micale
Journal:  Neurotox Res       Date:  2017-04-18       Impact factor: 3.911

3.  Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancy.

Authors:  J G Howland; B N Cazakoff; Y Zhang
Journal:  Neuroscience       Date:  2011-11-11       Impact factor: 3.590

4.  Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.

Authors:  Gen Kaneko; Basavaraju G Sanganahalli; Stephanie M Groman; Helen Wang; Daniel Coman; Jyotsna Rao; Peter Herman; Lihong Jiang; Katherine Rich; Robin A de Graaf; Jane R Taylor; Fahmeed Hyder
Journal:  Biol Psychiatry       Date:  2016-05-30       Impact factor: 13.382

5.  Acute N-methyl-D-aspartate receptor hypofunction induced by MK801 evokes sex-specific changes in behaviors observed in open-field testing in adult male and proestrus female rats.

Authors:  I Feinstein; M F Kritzer
Journal:  Neuroscience       Date:  2012-10-22       Impact factor: 3.590

6.  Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.

Authors:  Felipe V Gomes; Francisco S Guimarães; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-13       Impact factor: 5.176

7.  The Antioxidant N-Acetyl-L-Cysteine Restores the Behavioral Deficits in a Neurodevelopmental Model of Schizophrenia Through a Mechanism That Involves Nitric Oxide.

Authors:  Ana Lopes-Rocha; Thiago Ohno Bezerra; Roberta Zanotto; Inda Lages Nascimento; Angela Rodrigues; Cristiane Salum
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

8.  Neonatal stress-induced affective changes in adolescent Wistar rats: early signs of schizophrenia-like behavior.

Authors:  Carlos Eduardo Neves Girardi; Natália Cristina Zanta; Deborah Suchecki
Journal:  Front Behav Neurosci       Date:  2014-09-10       Impact factor: 3.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.